- Release Date: 12/12/25 10:02
- Summary: Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD
- Price Sensitive: No
- Download Document 205.15KB
- Forums
- ASX - By Stock
- MSB
- Ann: Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD
MSB
mesoblast limited
Add to My Watchlist
0.50%
!
$2.03
Ann: Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD
-
Top Stories
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
Last
$2.03 |
Change
0.010(0.50%) |
Mkt cap ! $2.617B | |||
| Open | High | Low | Volume |
| $2.09 | $2.12 | $2.03 | 3.401M |
Buyers (Bids)
| Vol. | Price($) |
|---|---|
| 9947 | $2.03 |
Sellers (Offers)
| Price($) | Vol. |
|---|---|
| $2.05 | 2078 |
| Last trade - 16.10pm 05/06/2026 (20 minute delay) ? |
Featured News
| MSB (ASX) Chart |